V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20166738 | 20063729 | 1.77 | null | Neo-adjuvant (N) | 2019-03-26 | 2019-03-31 | ECX | N | N | ECX | 101607135 |
| 20166744 | 20063730 | 1.74 | 104.4 | Neo-adjuvant (N) | 2016-02-17 | 2016-03-01 | ECX | 02 | N | ECX | 100227722 |
| 20166746 | 20063731 | 1.66 | 102.2 | Neo-adjuvant (N) | 2018-02-24 | 2018-03-13 | ECX | N | N | ECX | 100644732 |
| 20166747 | 20063732 | 1.73 | 78 | Curative (C) | 2016-07-07 | 2016-07-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101547687 |
| 20166754 | 20063733 | 1.75 | 65.6 | Neo-adjuvant (N) | 2018-09-07 | 2018-09-14 | ECX | 2 | N | ECX | 100893126 |
| 20166764 | 20063734 | 1.67 | 83.7 | Palliative (P) | 2017-04-04 | 2017-04-20 | ECX | N | Y | ECX | 100085685 |
| 20166765 | 20063735 | null | null | Palliative (P) | 2016-09-25 | 2016-10-11 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101510268 |
| 20166770 | 20063736 | 1.82 | 52 | Palliative (P) | 2019-07-26 | 2019-08-06 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100030496 |
| 20166772 | 20063737 | 1.76 | 84 | Adjuvant (A) | 2016-08-07 | 2016-08-27 | ECX | N | Y | ECX | 101672039 |
| 20166785 | 20063738 | 1.69 | 51.8 | Palliative (P) | 2020-01-05 | 2020-01-08 | ECX | N | N | ECX | 101267560 |
| 20166791 | 20063739 | 1.72 | 58.2 | Adjuvant (A) | 2019-03-02 | 2019-03-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100764499 |
| 20166793 | 20063740 | 1.73 | 68 | Palliative (P) | 2018-06-01 | 2018-06-16 | ECX | N | N | ECX | 101812132 |
| 20166796 | 20063741 | 1.61 | 90.4 | Adjuvant (A) | 2019-02-10 | 2019-02-17 | ECX | N | N | ECX | 101239344 |
| 20166804 | 20063742 | 1.63 | 61 | Neo-adjuvant (N) | 2017-06-30 | 2017-07-21 | ECX | 2 | N | ECX | 101653933 |
| 20166806 | 20063743 | 1.7 | 82.9 | Palliative (P) | 2016-12-20 | 2016-12-20 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100139677 |
| 20166808 | 20063744 | 1.73 | 95 | Palliative (P) | 2019-05-31 | 2019-06-10 | ECX | 2 | N | ECX | 100376002 |
| 20166814 | 20063745 | 1.75 | 51 | Neo-adjuvant (N) | 2016-02-02 | 2016-02-05 | ECX | N | null | ECX | 100952401 |
| 20166820 | 20063746 | 1.63 | 86.85 | Neo-adjuvant (N) | 2017-10-30 | 2017-11-07 | ECX | N | null | ECX | 100466825 |
| 20166824 | 20063747 | 1.71 | 55.6 | Curative (C) | 2019-07-21 | 2019-08-02 | ECX | 02 | N | ECX | 100990888 |
| 20166825 | 20063748 | 1.58 | 113.5 | Adjuvant (A) | 2017-10-22 | 2017-11-18 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100429113 |
| 20166830 | 20063749 | 1.73 | 67.15 | Adjuvant (A) | 2018-05-11 | 2018-06-05 | Gemcitabine + Capecitabine | 2 | null | CAPECITABINE + GEMCITABINE | 100982128 |
| 20166833 | 20063750 | 1.58 | 69.5 | Adjuvant (A) | 2018-09-03 | 2018-09-24 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100301592 |
| 20166834 | 20063751 | 1.71 | 72.9 | Palliative (P) | 2019-07-07 | 2019-07-11 | ECX | 02 | N | ECX | 100765174 |
| 20166839 | 20063752 | 1.67 | 78.5 | Neo-adjuvant (N) | 2018-07-29 | 2018-08-09 | ECX | N | N | ECX | 100694700 |
| 20166842 | 20063753 | 1.78 | 76 | Disease modification (D) | 2016-09-11 | 2016-09-18 | ECX | 02 | N | ECX | 100800129 |
| 20166852 | 20063754 | 1.54 | 70 | Palliative (P) | 2019-07-27 | 2019-08-17 | Gemcitabine + Capecitabine | N | N | CAPECITABINE + GEMCITABINE | 100211090 |
| 20166859 | 20063755 | 1.63 | 95.35 | Neo-adjuvant (N) | 2016-03-23 | 2016-04-08 | ECX | N | null | ECX | 101452425 |
| 20166860 | 20063756 | 1.58 | 70.4 | 03 | 2017-03-14 | 2017-04-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101078969 |
| 20166869 | 20063757 | 1.53 | null | Neo-adjuvant (N) | 2016-08-07 | 2016-08-21 | ECX | 02 | N | ECX | 100471515 |
| 20166872 | 20063758 | 1.61 | 58 | Neo-adjuvant (N) | 2017-04-30 | 2017-05-07 | ECX | 02 | N | ECX | 101424068 |
| 20166875 | 20063759 | 1.68 | 79.75 | Palliative (P) | 2017-07-14 | 2017-07-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100076576 |
| 20166879 | 20063760 | 1.55 | 64 | Neo-adjuvant (N) | 2017-06-22 | 2017-06-23 | ECX | N | N | ECX | 100465773 |
| 20166886 | 20063761 | 1.82 | 64 | Neo-adjuvant (N) | 2018-12-06 | 2018-12-14 | ECX | 02 | N | ECX | 101165544 |
| 20166898 | 20063762 | 1.74 | 77.8 | Neo-adjuvant (N) | 2017-05-06 | 2017-05-27 | ECX | N | N | ECX | 100390366 |
| 20166899 | 20063763 | 1.75 | 76.2 | Neo-adjuvant (N) | 2017-05-16 | 2017-05-16 | ECX | N | N | ECX | 101358495 |
| 20166912 | 20063764 | 1.83 | 51.4 | Palliative (P) | 2018-11-18 | 2018-11-27 | ECX | N | N | ECX | 101411033 |
| 20166915 | 20063765 | 1.64 | 67.15 | Curative (C) | 2018-01-13 | 2018-01-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101597132 |
| 20166916 | 20063766 | 1.76 | 88 | Neo-adjuvant (N) | 2019-01-19 | 2019-01-24 | ECX | N | N | ECX | 100099188 |
| 20166921 | 20063767 | 1.47 | 92 | Neo-adjuvant (N) | 2016-12-14 | 2017-01-07 | ECX | 02 | N | ECX | 101786821 |
| 20166923 | 20063768 | 1.61 | null | Palliative (P) | null | 2016-12-24 | ECX | null | N | ECX | 100280638 |
| 20166924 | 20063769 | 1.61 | 93.1 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-18 | ECX | 02 | N | ECX | 101336877 |
| 20166926 | 20063770 | 1.76 | 85 | Curative (C) | 2016-05-06 | 2016-05-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100047752 |
| 20166936 | 20063771 | 1.59 | 83 | Neo-adjuvant (N) | 2019-03-05 | 2019-03-10 | ECX | N | N | ECX | 100595569 |
| 20166939 | 20063772 | 1.78 | 103.2 | Palliative (P) | 2017-05-14 | 2017-05-14 | Gemcitabine + Capecitabine | 2 | N | CAPECITABINE + GEMCITABINE | 100207355 |
| 20166945 | 20063773 | 1.75 | 92 | Neo-adjuvant (N) | 2019-08-14 | 2019-08-15 | ECX | N | N | ECX | 100817766 |
| 20166946 | 20063774 | 1.57 | 84.9 | Neo-adjuvant (N) | null | 2017-04-11 | ECX | N | null | ECX | 100370588 |
| 20166951 | 20063775 | 1.65 | 65.7 | Neo-adjuvant (N) | 2017-05-02 | 2017-05-06 | ECX | N | N | ECX | 101173469 |
| 20166956 | 20063776 | 1.8 | 90.9 | Adjuvant (A) | 2018-03-05 | 2018-03-18 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101002786 |
| 20166959 | 20063777 | 1.73 | 114.2 | Palliative (P) | 2019-08-08 | 2019-08-17 | ECX | N | N | ECX | 100700150 |
| 20166963 | 20063778 | 1.61 | 45.2 | Neo-adjuvant (N) | 2016-03-25 | 2016-04-08 | ECX | N | null | ECX | 100851760 |